Uncategorized
Characterization of a Vitrocell VC1 Using Nicotine Dosimetry: An Essential Component Toward Standardized In Vitro Aerosol Exposure of Tobacco and Next Generation Nicotine Delivery Products
June 21, 2018The U.S. Food and Drug Administration has regulatory authority over tobacco products, including conventional cigarettes and next generation products (NGPs) such as e-cigarettes and tobacco heating products (THPs). There is a desire by the industry, regulators and animal protection organizations to incorporate non-animal test methods for tobacco product and NGP assessment. When assessing respiratory effects in vitro, reliable exposure systems that deliver aerosols to cellular/tissue cultures (such as human reconstructed airways or lung slices) at the air–liquid interface are needed. Using nicotine dosimetry, we report the...
Quality Assurance Associate
June 20, 2018We are seeking a full time Quality Assurance Associate to work in our Gaithersburg office. This is an exciting opportunity to join and grow with our team to contribute and share in our company vision: A day when methods based on humane, wisely applied science will be used by industry and the regulatory agencies to understand the true safety and efficacy of substances. The Quality Assurance Associate is asked to participate in the Quality Assurance monitoring and Good Laboratory Practice auditing...
Abstract Deadline Extended for ESTIV 2018
June 18, 2018The 20th International Congress on In Vitro Toxicology (ESTIV2018) happening in Berlin, 15-18 October, has extended their abstract submission deadline to July 1. Several grants and bursaries are also still open to applicants until July 1, including the PETA International Science Consortium early-career scientist award. Learn more about the meeting, including the scientific program, invited speakers, and how to register. ...
Holger Behrsing, PhD, Participates in Round Table Discussion on Non-Animal Approaches for Inhalation Toxicology
June 14, 2018Holger Behrsing, PhD, was recently invited to participate in an expert round table discussion convened on the development and implementation of 21st century non-animal approaches to assess the toxicity of inhaled substances. The discussion included perspectives from government, industry, nonprofit, and academic sectors on the advantages and challenges of using these approaches, ongoing efforts, and steps needed to gain widespread use and acceptance of these approaches. A transcript of the discussion has just been published in Applied In Vitro Toxicology, Vol....
Client Services Representative
June 8, 2018We are seeking a full time Client Services Representative to work in our Gaithersburg office. This is an exciting opportunity to join and grow with our team to contribute and share in our company vision: A day when methods based on humane, wisely applied science will be used by industry and the regulatory agencies to understand the true safety and efficacy of substances. Looking for a highly motivated, organized, and detail oriented person to serve as primary liaison between the Institute...
IIVS at EuroTox 2018
June 7, 2018IIVS President, Erin Hill, and Business Development Manager, Brent Gilbert, will be at the upcoming EuroTox 2018 in Brussels on September 3-5. Stop by our booth (#55) to chat with us or contact us to set up a meeting. In addition, IIVS will be presenting two posters. Text to be added. ...
Cruelty-Free Cosmetics Act Passes in California Senate.
June 1, 2018Yesterday, the California Senate passed the California Cruelty-Free Cosmetics Act (SB1249) bringing the state one step closer to becoming the first state in the U.S. to ban the sale of animal-tested cosmetics. The bill will now move on to the Assembly. If passed, SB1249 will outlaw the sale of all animal-tested cosmetics (including makeup, hair and skin care, and personal hygiene products) by 2020. Read more....
Holger Behrsing, PhD, Presenting at SIVB, June 5th, 2018
May 30, 2018Our very own Holger Behrsing, PhD, will be presenting at SIVB's Annual Meeting in St. Louis. His presentation on Tuesday, June 5th is titled "Pragmatic Use of State-of-the-Art Lung Models to Evaluate Exposure-induced, Adverse Pulmonary Effects" and will provide an overview of in vitro/ex vivo pulmonary models and how they can be incorporated into a screening/testing strategy for chemicals that can include more complex human pulmonary adverse events that are evaluable in modern 3D systems. Read More...
ASCCT Abstract Submission and Registration Now Open!
May 23, 2018Registration is now open for the 7th Annual ASCCT Meeting - Predictive Toxicology: Strategies for Implementing New Approaches - being held September 11-12, 2018, at the National Institutes of Health in Bethesda, MD. Learn More...
EU Parliament Calls for UN Convention on Use of Animal Testing for Cosmetics
May 8, 2018The non-binding resolution calls for a diplomatic push towards a global animal testing ban for cosmetics to be in place by 2023. Europe fully banned cosmetic animal testing in 2013, but it is still permitted in 80% of countries worldwide. Read article....